Brekiya 1 mg/mL injection (single-dose autoinjector) Images
Generic Name: dihydroergotamine
This medication has been identified as Brekiya 1 mg/mL injection (single-dose autoinjector). It is supplied by Amneal Pharmaceuticals LLC.
Brekiya is used in the treatment of Migraine; Cluster Headaches and belongs to the drug class antimigraine agents. Not for use in pregnancy. Brekiya 1 mg/mL injection (single-dose autoinjector) is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Brekiya
- Generic Name
- dihydroergotamine
- Strength
- 1 mg/mL injection (single-dose autoinjector)
- Availability
- Prescription only
- Drug Class
- Antimigraine agents
- Pregnancy Category
- X - Not for use in pregnancy
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amneal Pharmaceuticals LLC
- National Drug Code (NDC)
- 64896-0509
See also:
More about Brekiya (dihydroergotamine)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antimigraine agents
- Breastfeeding
Patient resources
Other brands
Migranal, Trudhesa, Atzumi, D.H.E. 45
Professional resources
Other brands
Migranal, Trudhesa, Atzumi, D.H.E. 45
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.